Literature DB >> 20649464

Improving the stability of α-conotoxin AuIB through N-to-C cyclization: the effect of linker length on stability and activity at nicotinic acetylcholine receptors.

Christopher J Armishaw1, Anders A Jensen, Lena D Balle, Krystle C M Scott, Lena Sørensen, Kristian Strømgaard.   

Abstract

Modification of α-conotoxin frameworks through cyclization via an oligopeptide linker has previously been shown as an effective strategy for improving in vivo stability. We have extended this strategy by investigating cyclic analogs of α-conotoxin AuIB, a selective α(3)β(4) nicotinic acetylcholine receptor (nAChR) antagonist, to examine a range of oligopeptide linker lengths on the oxidative formation of disulfide bonds, activity at nAChRs, and stability to degradation by chymotrypsin. Upon nondirected random oxidation, the ribbon isomer formed preferentially with the globular isomer occurring as a minor by-product. Therefore, a regioselective disulfide bond forming strategy was used to prepare the cAuIB-2 globular isomer in high yield and purity. The cAuIB-2 globular isomer exhibited a threefold decrease in activity for the α(3)β(4) nAChR compared to wild-type-AuIB, although it was selective for α(3)β(4) over α(7) and α(4)β(2) subtypes. On the other hand, the cAuIB-2 ribbon isomer was shown to be inactive at all three nAChR subtypes. Nonetheless, all of the cyclic analogs were found to be significantly more stable to degradation by chymotrypsin than wild-type AuIB. As such, the cAuIB-2 globular isomer could constitute a useful probe for studying the role of the α(3)β(4) nAChR in a range of in vivo experimental paradigms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20649464     DOI: 10.1089/ars.2010.3458

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  6 in total

1.  Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer.

Authors:  Xiaosa Wu; Yen-Hua Huang; Quentin Kaas; Peta J Harvey; Conan K Wang; Han-Shen Tae; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2017-08-28       Impact factor: 5.157

2.  Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.

Authors:  Nan Zheng; Sean B Christensen; Cheryl Dowell; Landa Purushottam; Jack J Skalicky; J Michael McIntosh; Danny Hung-Chieh Chou
Journal:  J Med Chem       Date:  2021-06-23       Impact factor: 7.446

Review 3.  Discovery, synthesis, and structure-activity relationships of conotoxins.

Authors:  Kalyana B Akondi; Markus Muttenthaler; Sébastien Dutertre; Quentin Kaas; David J Craik; Richard J Lewis; Paul F Alewood
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

4.  Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library.

Authors:  Yi-Pin Chang; Jayati Banerjee; Cheryl Dowell; Jinhua Wu; Reena Gyanda; Richard A Houghten; Lawrence Toll; J Michael McIntosh; Christopher J Armishaw
Journal:  J Med Chem       Date:  2014-04-03       Impact factor: 7.446

5.  Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB.

Authors:  Xincan Li; Shuai Wang; Xiaopeng Zhu; Dongting Zhangsun; Yong Wu; Sulan Luo
Journal:  Mar Drugs       Date:  2020-03-29       Impact factor: 5.118

Review 6.  α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia.

Authors:  Adam C Kennedy; Alessia Belgi; Benjamin W Husselbee; David Spanswick; Raymond S Norton; Andrea J Robinson
Journal:  Toxins (Basel)       Date:  2020-08-06       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.